comparemela.com

Latest Breaking News On - Harrow health daily - Page 1 : comparemela.com

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […]

Craig-hallum
Institutional-trading-of-harrow-health
Eton-pharmaceuticals-inc
Harrow-health
Envestnet-asset-management-inc
Surface-ophthalmics-inc
Securities-exchange-commission
Nasdaq
Wasatch-advisors-inc
Opaleye-management-inc
Harrow-health-inc
Prelude-capital-management

Harrow Health, Inc. (NASDAQ:HROW) CEO Buys $104,310.00 in Stock

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 9,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $11.59 per share, for a total transaction of $104,310.00. Following the completion of the acquisition, the chief executive officer now […]

Markl-baum
Surface-ophthalmics-inc
Rice-hall-james-associates
Harrow-health-company-profile
Jump-financial
Stifel-financial-corp
Harrow-health
Kennedy-capital-management
Pharmaceuticals-inc
Nasdaq
News-ratings-for-harrow-health-daily

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Markl-baum
Harrow-health-trading
Institutional-trading-of-harrow-health
Blackrock-inc
Vanguard-group-inc
Pharmaceuticals-inc
Harrow-health
Opaleye-management-inc
Morgan-stanley
Insider-activity-at-harrow-health
Securities-exchange-commission

Harrow Health, Inc. (NASDAQ:HROW) Expected to Earn Q1 2024 Earnings of ($0.25) Per Share

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley issued their Q1 2024 earnings per share estimates for shares of Harrow Health in a research note issued to investors on Thursday, March 21st. B. Riley analyst M. Mamtani forecasts that the company will post earnings of ($0.25) per share for the […]

Eton-pharmaceuticals-inc
Goldman-sachs-group-inc
Harrow-health
Nasdaq
Nuveen-asset-management
Harrow-health-stock
Barclays-plc
Surface-ophthalmics-inc
Pricet-rowe-associates-inc
News-ratings-for-harrow-health-daily
Vanguard-group-inc

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Harrow-health-inc
Quarter-for-harrow-health
News-ratings-for-harrow-health-daily
Pharmaceuticals-inc
Surface-ophthalmics-inc
Harrow-health
Nasdaq
Prelude-capital-management
Eton-pharmaceuticals-inc
Harrow-health-trading
Wasatch-advisors-inc

vimarsana © 2020. All Rights Reserved.